XML 48 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Share-based Compensation (Tables)
6 Months Ended
Dec. 31, 2022
Share-based Compensation  
Summary of stock option award activity

    

    

    

    

    

Weighted

Weighted-

Average

Average

Aggregate

Remaining

Exercise

Intrinsic

Contractual

(In thousands, except for weighted average price and life data)

    

Awards

    

Price

    

Value

    

Life (yrs.)

Outstanding at June 30, 2022

 

935

8.94

$

6.5

Forfeited, expired or repurchased

 

(23)

8.13

Outstanding at December 31, 2022

 

912

8.96

$

6.1

Vested and expected to vest at December 31, 2022

 

912

8.96

$

6.1

Exercisable at December 31, 2022

 

710

9.73

$

5.9

Summary of non-vested restricted stock awards

Weighted

Average Grant-date

Aggregate

(In thousands, except for weighted average price data)

    

Awards

    

Fair Value

    

Intrinsic Value

Non-vested at June 30, 2022

 

1,355

$

5.28

Vested

 

(551)

 

5.46

$

318

Forfeited

 

(23)

 

4.97

Non-vested at December 31, 2022

 

781

$

5.17

Schedule of allocation of share-based compensation

Three Months Ended

Six Months Ended

December 31, 

December 31, 

(In thousands)

    

2022

    

2021

    

2022

    

2021

Selling, general and administrative expenses

$

1,392

$

2,115

$

2,836

$

4,812

Research and development expenses

 

28

 

27

 

56

 

122

Cost of sales

 

112

 

167

 

219

 

393

Total

$

1,532

$

2,309

$

3,111

$

5,327

Tax benefit at statutory rate

$

345

$

519

$

700

$

1,199